← Open Payments lookup

TIFFANIE VILLASANA: Open Payments

NPI 1922216407 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,481 in 150 payments from 25 companies in 2025. Trend: 2023 $2,008 · 2024 $2,101 · 2025 $2,481

Food & beverage: $2,439Education: $43
CompanyPaymentsAmount
Corcept Therapeutics18$287
Insulet Corporation26$247
Abbott Laboratories14$209
Novo Nordisk Inc10$201
Currax Pharmaceuticals LLC20$168
Amneal Pharmaceuticals LLC11$164
Boehringer Ingelheim Pharmaceuticals, Inc.6$127
Tandem Diabetes Care, Inc.4$113
Lilly USA, LLC6$110
Xeris Pharmaceuticals, Inc.5$106

Products named: Korlym, Omnipod, FREESTYLE LIBRE, JARDIANCE, CONTRAVE, UNITHROID, Ozempic, t:slim X2 Insulin Pump with Control-IQ.

Industry payments across TX — which companies pay providers there.